Sarah Cannon Research Institute
Alicia Edge is an accomplished professional in laboratory operations and anatomic pathology support with over a decade of experience. Currently serving as Senior Manager of Laboratory Operations at Sarah Cannon Research Institute since January 2021, Alicia previously held roles at PathGroup from August 2012 to January 2021, including Histology Grossing Supervisor and Pathology Support Supervisor, where responsibilities included managing hospital pathology services and ensuring client satisfaction. Earlier experience includes roles at LabCorp as Support Team Lead, overseeing oncology sample processing. Alicia holds a Bachelor of Science in Healthcare Administration from Middle Tennessee State University and is currently pursuing a Master of Business Administration in Healthcare Management at Western Governors University.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.